Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

NCT04620759 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04620759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 14, 2021
Completion date
March 30, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, major depressive disorder